Nanotechnological approaches for the treatment of placental dysfunction: recent trends and future perspectives.

The transitory placenta develops during pregnancy and mediates the blood flow between the mother and the developing baby. Placental dysfunction, including but not limited to placenta accreta spectrum, fetal growth restriction, preeclampsia and gestational trophoblastic disease, arises from abnormal placental development and can result in significant adverse maternal and fetal health outcomes. Unfortunately, there is a lack of treatment alternatives for these disorders. Nanocarriers offer versatility, including extended circulation, organ-specific targeting and intracellular transport, finely tuning therapeutic placental interactions. This thorough review explores nanotechnological strategies for addressing placental disorders, encompassing dysfunction insights, potential drug-delivery targets and recent strides in placenta-targeted nanoparticle (NP) therapies, instilling hope for effective placental malfunction treatment.

Citation

Jian Zhao, Jungang Zhang, Yan Xu, Juan Dong, Qichao Dong, Guoqiang Zhao, Ying Shi. Nanotechnological approaches for the treatment of placental dysfunction: recent trends and future perspectives. Nanomedicine (London, England). 2023 Nov;18(26):1961-1978

Mesh Tags

PMID: 37990993

search → result